A Nagoya neurologist discovered he was better at moving research into the world than producing it at the bench. Eight years later, his 11-person company is using ordinary brain scans to tackle an expensive diagnostic bottleneck.
Its AI can release selected patients from an urgent cancer pathway without a dermatologist reviewing their images. The harder achievement is making that decision work inside a real health service.
Exo squeezed three ultrasound probes, real-time AI and the paperwork of a hospital imaging program into one pocket-sized system. The harder trick is making bedside scanning routine rather than exceptional.
NDR Medical Technology is a Singapore-based deep-tech company building AI-empowered interventional robotics for minimally invasive, image-guided surgery. Its Automated Needle Targeting (ANT) platform combines hardware and software to plan and align percutaneous needle placement with roughly ±1mm accuracy using a hospital's existing imaging equipment. Its flagship ANT-X robot received U.S. FDA 510(k) clearance in 2023 as the first automated device to aid kidney access for percutaneous nephrolithotomy, while ANT-C brings AI CT-based lesion targeting to procedures across the lung, liver, kidney and spine.
Qritive is a Singapore-based healthtech company building AI-powered digital pathology software that helps pathologists detect, grade and classify cancer from whole-slide images. Its Pantheon platform digitizes the entire histopathology workflow, and a suite of hardware-agnostic AI modules - covering prostate, colon, breast, gastric, lymph node metastasis and immunohistochemistry - assist pathologists in reaching faster, more consistent diagnoses. The company sells to hospitals, pathology labs and pharmaceutical partners across Asia-Pacific, the US and the Middle East.
Sandy Health is a San Francisco healthtech company building an AI-powered operations platform that acts as the financial layer for healthcare. It connects scheduling, intake, eligibility verification, prior authorization, an AI clinical scribe, and revenue intelligence into one system so providers can predict reimbursement before, during, and after every visit. Founded by cancer survivor and MIT-trained engineer Diego Saavedra-Kloss, Sandy targets the administrative friction that drains time and revenue from patient care.
Telepatia AI is a healthtech company building an 'AI Doctor' for Latin America - a clinical copilot that transcribes patient visits in real time, structures the medical record automatically, and surfaces evidence-based suggestions while the physician works. Founded by Colombians Nicolas Abad and Tomas Giraldo and incubated at Stanford, the platform integrates with 50+ hospital systems, claims to give physicians back roughly two hours a day, and has raised $42M total, including a $33M Series A led by Andreessen Horowitz. Its stated goal is to assist half of Latin America's 1.9 million doctors by the end of 2027.
DeLorean Artificial Intelligence is a Palm Beach, Florida-based healthcare AI company that builds predictive and interventive intelligence to forecast chronic disease and recommend next-best clinical actions before a patient gets sicker. Its flagship Medical AI platform, MARTI, analyzes structured and unstructured health records to predict events like hospitalizations and disease progression - and is described as the first medical AI to be biologically validated by independent third parties. Founded in 2019 by Dr. Severence MacLaughlin, the company also applies its predictive engine to sales/CRM, life sciences, financial services and other industries.